English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/111178
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 5 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing

Autor Zanuy, David; Sayago, Francisco J. ; Ballano, Gema ; Jiménez, Ana I. ; Cativiela, Carlos ; Alemán, Carlos
Palabras clave Tumor-homing peptide
Bioactive conformation dynamics
Computational design
Peptide synthesis
Fecha de publicación 2013
EditorSpringer
Citación Journal of Computer-Aided Molecular Design 27(1): 31-43 (2013)
ResumenWe present a chemical strategy to engineer analogs of the tumor-homing peptide CREKA (Cys-Arg-Glu-Lys-Ala), which binds to fibrin and fibrin-associated clotted plasma proteins in tumor vessels (Simberg et al. in Proc Natl Acad Sci USA 104:932-936, 2007) with improved ability to inhibit tumor growth. Computer modeling using a combination of simulated annealing and molecular dynamics were carried out to design targeted replacements aimed at enhancing the stability of the bioactive conformation of CREKA. Because this conformation presents a pocket-like shape with the charged groups of Arg, Glu and Lys pointing outward, non-proteinogenic amino acids α-methyl and N-methyl derivatives of Arg, Glu and Lys were selected, rationally designed and incorporated into CREKA analogs. The stabilization of the bioactive conformation predicted by the modeling for the different CREKA analogs matched the tumor fluorescence results, with tumor accumulation increasing with stabilization. Here we report the modeling, synthetic procedures, and new biological assays used to test the efficacy and utility of the analogs. Combined, our results show how studies based on multi-disciplinary collaboration can converge and lead to useful biomedical advances. © 2012 Springer Science+Business Media Dordrecht.
URI http://hdl.handle.net/10261/111178
DOI10.1007/s10822-012-9623-5
Identificadoresdoi: 10.1007/s10822-012-9623-5
issn: 0920-654X
e-issn: 1573-4951
Aparece en las colecciones: (ISQCH) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.